methyldopa has been researched along with Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gueyffier, F; Musini, VM; Puil, L; Salzwedel, DM; Wright, JM | 1 |
| Holme, I; Kjeldsen, SE | 1 |
1 review(s) available for methyldopa and Stroke
| Article | Year |
|---|---|
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cause of Death; Coronary Disease; Humans; Hypertension; Methyldopa; Middle Aged; Myocardial Infarction; Patient Dropouts; Propranolol; Randomized Controlled Trials as Topic; Stroke; Young Adult | 2017 |
1 other study(ies) available for methyldopa and Stroke
| Article | Year |
|---|---|
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.
Topics: Adult; Aged; Antihypertensive Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Kaplan-Meier Estimate; Longitudinal Studies; Male; Methyldopa; Middle Aged; Myocardial Infarction; Norway; Proportional Hazards Models; Propranolol; Randomized Controlled Trials as Topic; Severity of Illness Index; Sodium Chloride Symporter Inhibitors; Stroke; Survival Rate | 2015 |